Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Julphar
Argus Health
Fuji
Chubb
Express Scripts
UBS
Farmers Insurance
Fish and Richardson

Generated: April 26, 2018

DrugPatentWatch Database Preview

OXY-KESSO-TETRA Drug Profile

« Back to Dashboard

Which patents cover Oxy-kesso-tetra, and what generic alternatives are available?

Oxy-kesso-tetra is a drug marketed by Ferrante and is included in one NDA.

The generic ingredient in OXY-KESSO-TETRA is oxytetracycline hydrochloride. There are thirty-six drug master file entries for this compound. Additional details are available on the oxytetracycline hydrochloride profile page.
Drug patent expirations by year for OXY-KESSO-TETRA
Synonyms for OXY-KESSO-TETRA
(2E,4S,4aR,5S,5aR,6S,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione hydrochloride
(2Z,4S,4aR,5S,5aR,6S,12aS)-2-[amino(hydroxy)methylene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione hydrochloride
(2Z,4S,4aR,5S,5aR,6S,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione hydrochloride
(4S,4AR,5S,5AR,6S,12AR)-4-(DIMETHYLAMINO)-1,5,6,10,11,12A-HEXAHYDROXY-6-METHYL-3,12-DIOXO-3,4,4A,5,5A,6,12,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE HYDROCHLORIDE
(4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide hydrochloride
(4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride
(4S,5R,6S,12aS)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide hydrochloride
(4S,5S,6S,12aS,4aR,5aR)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl -1,11-dioxo-4,5,6,12a,4a,5a-hexahydronaphthacene-2-carboxamide, chloride
102323-64-8
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, monohydrochloride
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, (4S-(4alpha,4aalpha,5alpha,5aalpha,6beta,12aalpha))-
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, (4S,4aR,5S,5aR,6S,12aS)-
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, [4S-(4alpha,4aalpha,5alpha,5aalpha,6beta,12aalpha)]-
2058-46-0
4- (dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride
4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride
4U7K4N52ZM
5-Hydroxytetracycline hydrochloride
5-Hydroxytetracycline monohydrochloride
5-Oxyetracycline
61794-35-2
72034-96-9
79-57-2 (Parent)
885678-73-9
90438-85-0
AB0011435
AB1004856
Abbocin
AC-11614
AC1NR4G1
AC1NWAPI
AI3-50164
AK481343
AKOS015950811
Alamycin
AN-19823
Aquacycline
Bi Steclin
Biosolvomycin
Biotet
bisolvomyci n
Bisolvomycin
C-22923
C13055
C22H24N2O9.HCl
CAS-2058-46-0
Caswell No. 628
CCG-40206
CCRIS 200
CHEBI:31953
CHEMBL1607480
Chrysocin
component of Terramycin Topical Ointment
CPD001614498
D01596
Dalimycin
Dalinmycin
DSSTox_CID_1097
DSSTox_GSID_21097
DSSTox_RID_75939
DTXSID5021097
EINECS 218-161-2
Elinton
Engemycin
EPA Pesticide Chemical Code 006308
HMS1920F04
Hydroxytetracycline monohydrochloride
Hydroxytetrazyklinhydrochlorid
Ia-Loxin
Intaloxin
KB-79741
Liquachel
Liquamycin injectable
LS-993
Macodyn
MCULE-3329146897
Mepatar
MolPort-003-666-253
Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-he xahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, (4S-(4alpha,4aalpha,5alpha,5aalpha,6beta,12aalpha))-
Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, (4S-(4alpha,4aalpha,5alpha,5aalpha,6beta,12aalpha))-
NC00526
NCGC00091268-01
NCGC00164443-01
NCGC00254367-01
NCGC00259399-01
Neo-oxy 100/100 MR
NSC 9169
NSC-757262
NSC757262
O0475
OTC
Otetryn
Oxacycline
Oxamycen
Oxatet
Oxatets
Oxlopar
Oxy WS
Oxy-DE 250
Oxy-Dumocyclin
Oxy-Rivo
Oxy-Terachel
Oxy-Tet 50
OXY-WS
Oxybiocycline
Oxycycline
Oxydon
Oxyject
Oxyject 100
Oxymycin
Oxymykoin
Oxysteclin
Oxytet
Oxytetracycline HCl
OXYTETRACYCLINE HYDROCHLORIDE
Oxytetracycline hydrochloride (internal use)
Oxytetracycline hydrochloride (JP17/USP)
Oxytetracycline hydrochloride [USAN:JAN]
Oxytetracycline hydrochloride [USP:JAN]
Oxytetracycline hydrochloride, >=95% (HPLC), crystalline
Oxytetracycline hydrochloride, can be used as secondary standard
Oxytetracycline hydrochloride, can be used as secondary standard
Oxytetracycline hydrochloride, European Pharmacopoeia (EP) Reference Standard
Oxytetracycline Hydrochloride, pharmaceutical secondary standard; traceable to USP, PhEur and BP
Oxytetracycline hydrochloride, United States Pharmacopeia (USP) Reference Standard
Oxytetracycline hydrochloride, VETRANAL(TM), analytical standard
Oxytetracycline Monohydrochloride
Oxytetracycline.HCl
Oxytetracyclinehydrochloride
Oxytetracyclini hydrochloridum
Oxytetral
Oxytetrin
Oxytracyl
Oxyvet
Pharmakon1600-01500457
PL009887
SAM002554919
SCHEMBL124996
SPECTRUM1500457
ST067106
Stecsolin
Stevacin
Terraject
Terramycin
Terramycin (TN)
Terramycin hydrochloride
Tetra-Tablinen
Tetracycline, 5-oxy-
TM 5
TM 5 (VAN)
Tox21_111109
Tox21_201850
Tox21_300601
Toxinal
UNII-4U7K4N52ZM
Unimycin
Uri-Tet
Vendarcin

US Patents and Regulatory Information for OXY-KESSO-TETRA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ferrante OXY-KESSO-TETRA oxytetracycline hydrochloride CAPSULE;ORAL 060179-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
UBS
Merck
Deloitte
McKinsey
QuintilesIMS
Johnson and Johnson
Baxter
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.